Virtual Library
Start Your Search
Bruce Pyenson
Author of
-
+
ES08 - Critical Concerns in Screening (ID 11)
- Event: WCLC 2019
- Type: Educational Session
- Track: Screening and Early Detection
- Presentations: 1
- Now Available
- Moderators:Ugo Pastorino, John Kirkpatrick Field
- Coordinates: 9/08/2019, 13:30 - 15:00, Copenhagen (1980)
-
+
ES08.06 - Cost Effectiveness of Comprehensive Screening and Smoking Cessation Programmes (Now Available) (ID 3196)
13:30 - 15:00 | Presenting Author(s): Bruce Pyenson
- Abstract
- Presentation
Abstract
There is broad consensus that lung cancer screening with low-dose CT is cost-effective. However, there has been slow take-up in the US where it is covered by commercial insurance and by the federal Medicare program.
One way to optimize LC screening is to consider screening as part of an integrated program that specializes in population health for the cluster of smoking-related illness. There are four components of this,
LC screening centers can provide high-quality screening and systematic follow-up and appropriate referrals
Imaging for LC screening can quantify cardiac calcification, COPD, and osteoporosis, all of which may be associated with smoking
LC screening centers can operate as a center for smoking cessation, exercise counseling, and adherence support
For the 1.5 million annual indeterminant pulmonary nodules in the US, LC screening centers can provide appropriate follow-up. The vast majority of such cases receive no follow-up.
There are both economic and financial consequences for integrated screening. The economic consequences are measured in cost-effectiveness. The financial consequences are attracting high-utilizing people away from lower-quality providers, which can offset the loss of income from treating late stage lung cancers.
Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.
-
+
S01 - IASLC CT Screening Symposium: Forefront Advances in Lung Cancer Screening (Ticketed Session) (ID 96)
- Event: WCLC 2019
- Type: Symposium
- Track: Screening and Early Detection
- Presentations: 1
- Now Available
- Moderators:John Kirkpatrick Field, James L Mulshine
- Coordinates: 9/07/2019, 07:00 - 12:00, Colorado Springs (1994)
-
+
S01.18 - Cost Effectiveness (Now Available) (ID 3643)
07:00 - 12:00 | Presenting Author(s): Bruce Pyenson
- Abstract
- Presentation
Abstract
There is broad consensus that lung cancer screening with low-dose CT is cost-effective. However, there has been slow take-up in the US where it is covered by commercial insurance and by the federal Medicare program.
One way to optimize LC screening is to consider screening as part of an integrated program that specializes in population health for the cluster of smoking-related illness. There are four components of this,
LC screening centers can provide high-quality screening and systematic follow-up and appropriate referrals
Imaging for LC screening can quantify cardiac calcification, COPD, and osteoporosis, all of which may be associated with smoking
LC screening centers can operate as a center for smoking cessation, exercise counseling, and adherence support
For the 1.5 million annual indeterminant pulmonary nodules in the US, LC screening centers can provide appropriate follow-up. The vast majority of such cases receive no follow-up.
There are both economic and financial consequences for integrated screening. The economic consequences are measured in cost-effectiveness. The financial consequences are attracting high-utilizing people away from lower-quality providers, which can offset the loss of income from treating late stage lung cancers.
Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.
